CMS Establishes Medicare Payment Policy for COVID-19 Antibody Treatment

Published date23 November 2020
Subject MatterMedicare,Out-of-Pocket Expenses,Health Care Providers,Inpatient Prospective Payment System (IPPS),Coronavirus/COVID-19,Public Health Emergency,Centers for Medicare & Medicaid Services (CMS)
AuthorRebecca Gittelson
Law FirmKing & Spalding

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT